 epirubicin cardiotox studi patient advanc breast cancer cardiotox epirubicin epi ecg multipl ecg-gat radionuclid determin left ventricular eject fraction lvef rest patient advanc breast cancer epi dose day week vindesin schedul median cumul dose epi rang patient congest heart failur chf patient epi none chf patient dose chf confid limit patient epi chf confid limit patient due cardiotox risk epi cardiotox present schedul consider dose dose risk chf decreas dose neglig patient preval chf sensit lvef high due low incid chf patient epi preval chf sensit specif result lvef valu predictor chf